© 2021 MJH Life Sciences and Contemporary OB/GYN. All rights reserved.
© 2021 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
March 25, 2021
Missing just 1 screening can lead to significant increase in risk, investigators say.
March 22, 2021
In honor of International Women’s Day, CURE® compiled some recent news and updates in cancer research that you may have missed.
March 18, 2021
A team of international researchers partnered with the National Cancer Institute and Mayo Clinic to conduct a research opportunity that led to unexpected findings.
December 25, 2020
Following the 2020 San Antonio Breast Cancer Symposium, Erika P. Hamilton, MD, and William J. Gradishar, MD, shared their key takeaways and insights from the most impactful data presented during this year’s meeting.
December 22, 2020
A new study found that the rate of cancer in adolescents and young adults increased by 29/6% between 1973 and 2015.
November 19, 2020
Merck earned a new indication for pembrolizumab (Keytruda), in combination with chemotherapy, to treat locally recurrent unresectable or metastatic triple-negative breast cancer (TNBC).
November 10, 2020
Study shows implementing the newly cleared software can slightly improve sensitivity and false negatives.
October 27, 2020
From OncLive, five experts share their perspectives and opinions on the latest research related to triple-negative breast cancer.
October 07, 2020
In a recent video from OncLive, Erika P. Hamilton, MD, highlights the initial findings from the ongoing phase 1b/2 LIO-trial in advanced metastatic tumors.
September 22, 2020
According to new research, women with ductal carcinoma in situ (DCIS) are more than three times as likely to suffer from breast cancer mortality than women in the general population.